Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for STRATA Skin Sciences (SSKN) over the last 12 years, with Q3 2025 value amounting to $2.5 million.

  • STRATA Skin Sciences' Other Operating Expenses fell 1684.84% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year increase of 1297.46%. This contributed to the annual value of $16.2 million for FY2024, which is 597.11% up from last year.
  • Per STRATA Skin Sciences' latest filing, its Other Operating Expenses stood at $2.5 million for Q3 2025, which was down 1684.84% from $3.5 million recorded in Q2 2025.
  • STRATA Skin Sciences' Other Operating Expenses' 5-year high stood at $6.9 million during Q4 2024, with a 5-year trough of $2.5 million in Q3 2025.
  • Its 5-year average for Other Operating Expenses is $3.6 million, with a median of $3.4 million in 2023.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first soared by 11914.01% in 2021, then plummeted by 1934.79% in 2024.
  • Over the past 5 years, STRATA Skin Sciences' Other Operating Expenses (Quarter) stood at $3.7 million in 2021, then grew by 1.77% to $3.8 million in 2022, then soared by 33.26% to $5.0 million in 2023, then soared by 37.49% to $6.9 million in 2024, then plummeted by 63.71% to $2.5 million in 2025.
  • Its Other Operating Expenses was $2.5 million in Q3 2025, compared to $3.5 million in Q2 2025 and $3.0 million in Q1 2025.